Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Long Term Debt 2017–2025
Puma Biotechnology Inc. annual long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Puma Biotechnology Inc. long term debt as of December 31, 2025: 22.7M, a 66.66% decrease year-over-year.
- Puma Biotechnology Inc. long term debt for 2025 were 22.7M, a 66.66% decrease from 2024.
- Puma Biotechnology Inc. long term debt for 2024 were 68.0M, a 33.33% decrease from 2023.
- Puma Biotechnology Inc. long term debt for 2023 were 102.0M, a 0.00% increase from 2022.
- Puma Biotechnology Inc. long term debt for 2022 were 102.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Puma Biotechnology Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $23 |
| 2024 | $68 |
| 2023 | $102 |
| 2022 | $102 |
| 2021 | $102 |
| 2020 | $84 |
| 2019 | $95 |
| 2018 | $152 |
| 2017 | $48 |
Puma Biotechnology Inc. Long Term Debt — FAQ
Puma Biotechnology Inc. (PBYI) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBYI's long term debt history?
The chart and table above show Puma Biotechnology Inc.'s long term debt by year and by quarter, including the growth rate.